سعر ميسبورين 1جم فيال للحقن الوريدي 1000 مجم 2025

Ceftriaxone 1 g powder for injection in a vial for intravenous use; third-generation cephalosporin antibiotic.

• Serious infections caused by susceptible bacteria: lower respiratory tract infections, acute bacterial otitis media, skin and skin-structure infections, urinary tract infections, uncomplicated gonorrhoea, pelvic inflammatory disease, bacterial septicaemia, bone and joint infections, intra-abdominal infections, meningitis, and surgical prophylaxis.Population: Adults and pediatric patientsDailyMed (U.S. National Library of Medicine)

• Most common: local reactions (pain, induration, tenderness at IM site; phlebitis after IV), eosinophilia (6%), thrombocytosis (5.1%), elevated liver transaminases (about 3%), diarrhoea (2.7%), leukopenia (2.1%) and rash (1.7%).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to ceftriaxone, other cephalosporins or any excipient.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Premature neonates up to a postmenstrual age of 41 weeks and hyperbilirubinaemic neonates.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Neonates (28 days or younger) requiring or expected to require calcium-containing IV solutions (risk of ceftriaxone-calcium precipitation).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Serious, occasionally fatal hypersensitivity (anaphylactic) reactions; use with caution in patients with penicillin or other beta-lactam allergy.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Do not mix with calcium-containing diluents or solutions; ceftriaxone-calcium precipitates have caused fatal reactions in neonates.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Clostridioides difficile-associated diarrhoea may occur during or after treatment.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Calcium-containing IV solutions (e.g., Ringer's, Hartmann's, parenteral nutrition)Risk of ceftriaxone-calcium precipitation; do not mix or co-administer via the same line; contraindicated in neonates.DailyMed (U.S. National Library of Medicine)
• Vitamin K antagonists (e.g., warfarin)Ceftriaxone may alter prothrombin time and increase bleeding risk; monitor coagulation.DailyMed (U.S. National Library of Medicine)

• Animal studies showed no evidence of fetal harm; there are no adequate and well-controlled studies in pregnant women, so use during pregnancy only if clearly needed.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Ceftriaxone is excreted in human milk at low concentrations; use with caution in nursing women.International label, same formulation · DailyMed (U.S. National Library of Medicine)

English text not available for this section.